Rosuvastatin (20mg), Clopidogrel (75mg) ROUSTRIN CV 20 distinct medications often prescribed together to manage cardiovascular conditions and reduce the risk of heart-related events.ROUSTRIN CV 20 medication serves a different purpose, and their combination may be recommended based on an individual's specific medical needs. ROUSTRIN CV 20 is a statin medication that works by inhibiting an enzyme called HMG-CoA reductase. ROUSTRIN CV 20 enzyme is involved in the production of cholesterol in the liver. ROUSTRIN CV 20 blocking this enzyme, rosuvastatin reduces the production of LDL (low-density lipoprotein) cholesterol and increases the liver's ability to remove LDL cholesterol from the bloodstream. ROUSTRIN CV 20 is prescribed to lower LDL cholesterol levels and improve overall lipid profiles. ROUSTRIN CV 20 is an antiplatelet medication that helps prevent the formation of blood clots by inhibiting platelet activation and aggregation. ROUSTRIN CV 20 works by blocking specific receptors on the surface of platelets, making them less likely to stick together and form clots. ROUSTRIN CV 20 is prescribed to reduce the risk of heart attacks, strokes, and other cardiovascular events in individuals at risk, particularly those with a history of recent heart attack, stroke, or peripheral artery disease. ROUSTRIN CV 20 is often used in combination with aspirin or as an alternative to aspirin in certain cases. ROUSTRIN CV 20 is sometimes prescribed when an individual has both elevated LDL cholesterol levels (requiring statin therapy) and a heightened risk of cardiovascular events (requiring antiplatelet therapy). ROUSTRIN CV 20 combination should be used under the guidance of a healthcare provider, and regular monitoring of lipid profiles and platelet function is necessary to ensure safety and efficacy. ROUSTRIN CV 20 essential to follow your healthcare provider's instructions regarding the use of these medications and to discuss any concerns or potential side effects with them. ROUSTRIN CV 20 modifications, such as a heart-healthy diet, regular exercise, and smoking cessation, are typically recommended as part of cardiovascular risk reduction. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now:https://www.sterisonline.com/product/roustrin-cv-20-133365